Signaling pathways
-
BA2114 N-p-trans-CoumaroyltyramineSummary: N-p-trans-Coumaroyltyramine is a cinnamoylphenethylamide isolated from Polygonum cinnamoylphenethylamide. - BA2121 CarbosulfanSummary: Potent inhibitor of CYP3A4, moderate inhibitor of CYP1A1/2 and CYP2C19.
- BA2124 DSM502Summary: DSM502 is a pyrrole-based inhibitor of dihydroorotic acid dehydrogenase.
- BA2126 MMV009085Summary: MMV009085 is a potent Plasmodium falciparum hexose transporter-specific inhibitor and a potential anti-malarial compound.
- BA2128 RYL-552Summary: RYL-552 is a mitochondrial electron transport chain inhibitor.
- BA2129 NPD-001Summary: NPD-001 is a potent phosphodiesterase and inhibitor of Trypanosoma brucei.
- BA2133 AmoscanateSummary: Amoscanate (CGP4540) is a phenyl isothiocyanate in which the hydrogen in the para position is replaced by a 4-nitroaniline group.
- BA2134 VU041Summary: VU041 was the first submicromolar affinity and channeling inhibitor with values of 2.5 μM and 1.7 μM, respectively.
- BA2135 ColumbinSummary: Columbin is an orally active diterpene furanolide with anti-inflammatory and anti-trypanosomal effects.
- BA2138 KDU731Summary: KDU731, an orally active inhibitor that blocks Cryptosporidium infection in vitro and in vivo.